Increased Frequency of Distinct TSC2 Allelic Variants in Focal Cortical Dysplasias with Balloon Cells and Mineralization
Overview
Authors
Affiliations
Focal cortical dysplasias with balloon cells (FCD(IIb)) usually present with characteristic imaging and molecular features, that is, a transmantle sign on fluid-attenuated inversion recovery MRI and abundance of allelic variants of the tuberous sclerosis gene 1 (TSC1). Recently, we observed several mineralized lesions (n = 5) lacking this MRI pattern and which surprisingly turned out as FCD(IIb) upon neuropathological examination. These mineralized FCD(IIb) revealed an increased frequency of TSC2 allelic variants but not TSC1 (intron 31: 60% vs. 11% in controls; P = 0.0164, exon 41: 40% vs. 6.5% in controls; P = 0.0441). Mineralized FCD(IIb) have a favorable postsurgical outcome and need consideration in the presurgical differential diagnosis of calcified lesions associated with pharmacoresistant focal epilepsies.
Silvennoinen K, Gawel K, Tsortouktzidis D, Pitsch J, Alhusaini S, van Loo K Acta Neuropathol. 2022; 144(1):107-127.
PMID: 35551471 PMC: 9217876. DOI: 10.1007/s00401-022-02429-0.
Surgery for focal cortical dysplasia in children using intraoperative mapping.
Terra V, Thome U, Rosset S, Funayama S, Dos Santos A, Santos M Childs Nerv Syst. 2014; 30(11):1839-51.
PMID: 25296545 DOI: 10.1007/s00381-014-2459-7.
Vargas W, Heier L, Rodriguez F, Bergner A, Yohay K Neuroimage Clin. 2014; 4:258-65.
PMID: 24501699 PMC: 3913834. DOI: 10.1016/j.nicl.2013.12.010.
Mammalian target of rapamycin (mTOR) pathways in neurological diseases.
Wong M Biomed J. 2013; 36(2):40-50.
PMID: 23644232 PMC: 3880546. DOI: 10.4103/2319-4170.110365.
Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target.
Galanopoulou A, Gorter J, Cepeda C Epilepsia. 2012; 53(7):1119-30.
PMID: 22578218 PMC: 3389589. DOI: 10.1111/j.1528-1167.2012.03506.x.